220 results on '"Sabit, Hemragul"'
Search Results
2. α-SMA positive vascular mural cells suppress cyst formation in hemangioblastoma
3. Non-occlusive mesenteric ischemia during bevacizumab treatment for glioblastoma: a case report
4. SMURF2 phosphorylation at Thr249 modifies glioma stemness and tumorigenicity by regulating TGF-β receptor stability
5. Leukemia-Associated Rho Guanine Nucleotide Exchange Factor and Ras Homolog Family Member C Play a Role in Glioblastoma Cell Invasion and Resistance
6. Recurrence of an extracranial internal carotid artery aneurysm treated with STA-MCA bypass and trapping due to neovascularization from an ascending pharyngeal artery: illustrative case
7. Ependymoma with C11orf95-MAML2 fusion: presenting with granular cell and ganglion cell features
8. Ligand-dependent EphB4 activation serves as an anchoring signal in glioma cells
9. Nuclear transport surveillance of p53 by nuclear pores in glioblastoma
10. Potential therapeutic effect of targeting glycogen synthase kinase 3β in esophageal squamous cell carcinoma
11. Therapeutic potential of pentamidine for glioma‐initiating cells and glioma cells through multimodal antitumor effects
12. Supplementary Figure S1 from Glycogen Synthase Kinase 3β Sustains Invasion of Glioblastoma via the Focal Adhesion Kinase, Rac1, and c-Jun N-Terminal Kinase-Mediated Pathway
13. Supplementary Table S2 from Glycogen Synthase Kinase 3β Sustains Invasion of Glioblastoma via the Focal Adhesion Kinase, Rac1, and c-Jun N-Terminal Kinase-Mediated Pathway
14. Supplementary Figure Legends from Glycogen Synthase Kinase 3β Sustains Invasion of Glioblastoma via the Focal Adhesion Kinase, Rac1, and c-Jun N-Terminal Kinase-Mediated Pathway
15. Data from Glycogen Synthase Kinase 3β Sustains Invasion of Glioblastoma via the Focal Adhesion Kinase, Rac1, and c-Jun N-Terminal Kinase-Mediated Pathway
16. Serine/Threonine Kinase MLK4 Determines Mesenchymal Identity in Glioma Stem Cells in an NF-κB-dependent Manner
17. Figure S1 from Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma
18. Data from Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma
19. Supplementary figure legends from Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma
20. COL1A2 inhibition suppresses glioblastoma cell proliferation and invasion
21. Intra-Brain and Plasma Levels of L-Serine Are Associated with Cognitive Status in Patients with Chronic Kidney Disease
22. Radiation-induced gliomas: a report of four cases and analysis of molecular biomarkers
23. STEM-17. IDENTIFICATION OF LOMERIZINE, A PROPHYLACTIC DRUG FOR MIGRAINES, AS A POTENTIAL ANTI-GLIOBLASTOMA DRUG
24. Tumor Microenvironment in Glioma Invasion
25. Identification of lomerizine originally for migraine as a potential anti-glioblastoma drug
26. Characterizing invading glioma cells based on IDH1-R132H and Ki-67 immunofluorescence
27. Epithelioid glioblastoma arising from pleomorphic xanthoastrocytoma with the BRAF V600E mutation
28. Progressive adult primary glioblastoma in the medulla oblongata with an unmethylated MGMT promoter and without an IDH mutation
29. SMURF2 phosphorylation at Thr249 modifies the stemness and tumorigenicity of glioma stem cells by regulating TGF-β receptor stability
30. Glycogen synthase kinase 3β inhibition sensitizes human glioblastoma cells to temozolomide by affecting O6-methylguanine DNA methyltransferase promoter methylation via c-Myc signaling
31. Ependymoma with C11orf95-MAML2 fusion: presenting with granular cell and ganglion cell features
32. BIOM-21. CORRELATION BETWEEN EPHRIN-A2 EXPRESSION AND PROGNOSIS IN PATIENTS WITH GLIOBLASTOMA
33. Identification of 2-Fluoropalmitic Acid as a Potential Therapeutic Agent Against Glioblastoma
34. RBPJ contributes to the malignancy of glioblastoma and induction of proneural‐mesenchymal transition via IL‐6‐STAT3 pathway
35. Superficial Siderosis Associated with Long-Term Recurrence of Pilocytic Astrocytoma in an Elderly Person
36. Gelsolin inhibits malignant phenotype of glioblastoma and is regulated by miR‐654‐5p and miR‐450b‐5p
37. Activation of MAP kinases, Akt and PDGF receptors in injured peripheral nerves
38. THE ROLE OF PLATELET-DERIVED GROWTH FACTOR RECEPTOR ß IN THE ACTIVATION OF MOUSE HEPATIC STELLATE CELLS
39. Deletion of the PDGFR-β Gene Affects Key Fibroblast Functions Important for Wound Healing
40. Mouse brains deficient in neuronal PDGF receptor-β develop normally but are vulnerable to injury
41. ZFH4 protein is expressed in many neurons of developing rat brain
42. Enhanced expression of basement-membrane-type heparan sulfate proteoglycan in tumor fibro-myxoid stroma of intrahepatic cholangiocarcinoma
43. CBMS-12 PENTAMIDINE; TRANSLATIONAL RESEARCH FOR A NEW CHEMOTHERAPY TARGETING ON GLIOMA CELLS AND GLIOMA STEM CELLS USING DRUG REPOSITIONING
44. CBMT-18. THE ROLE OF BIOMARKER CANDIDATE GELSOLIN AND ITS MICRORNAS IN GLIOBLASTOMA
45. PATH-37. PROGNOSTIC ROLE OF TERT PROMOTER MUTATIONS IMPROVES THE STRATIFICATION OF IDH-MUTATED LOWER GRADE GLIOMA
46. DDIS-25. PENTAMIDINE; A NEW CHEMOTHERAPY TARGETING ON GLIOMA STEM LIKE CELLS
47. DDIS-05. IDENTIFICATION OF 2-FLUORO PALMITIC ACID AS A POTENTIAL THERAPEUTIC AGENT AGAINST GLIOBLASTOMA
48. Identification of GSK3β inhibitor kenpaullone as a temozolomide enhancer against glioblastoma
49. Case of metastatic glioblastoma with primitive neuronal component to the lung
50. Fibulin‐7 is overexpressed in glioblastomas and modulates glioblastoma neovascularization through interaction with angiopoietin‐1
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.